Morningstar Investment Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,406
Closed -$218K 195
2024
Q3
$218K Buy
+1,406
New +$210K ﹤0.01% 392
2016
Q1
Sell
-4,393
Closed -$313K 218
2015
Q4
$313K Buy
+4,393
New +$295K 0.01% 190
2015
Q3
Sell
-4,382
Closed -$318K 218
2015
Q2
$318K Sell
4,382
-5,961
-58% -$440K 0.01% 188
2015
Q1
$795K Sell
10,343
-27,398
-73% -$1.96M 0.03% 162
2014
Q4
$2.53M Buy
37,741
+2,672
+8% +$169K 0.12% 126
2014
Q3
$2.13M Buy
35,069
+4,112
+13% +$253K 0.11% 133
2014
Q2
$1.82M Buy
30,957
+26,143
+543% +$1.53M 0.11% 127
2014
Q1
$279K Buy
+4,814
New +$258K 0.02% 183

Other funds holding DGX

Morningstar Investment Services's DGX Position: Q4 2024 in Review

Morningstar Investment Services sold out of Quest Diagnostics (DGX) in Q4 2024, closing a stake of 1,406 shares — an estimated $218K sold.

Morningstar Investment Services first reported a position in DGX in Q1 2014 and held it in 8 quarters. The position peaked at $2.53M in Q4 2014. 896 funds tracked by Wall St. Rank hold DGX as of Q4 2024.

  • Morningstar Investment Services reported no remaining Quest Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Morningstar Investment Services sold 1,406 Quest Diagnostics shares in Q4 2024, an estimated $218K.
  • Morningstar Investment Services first reported a position in Quest Diagnostics in Q1 2014 and held it in 8 quarters.
  • Morningstar Investment Services's Quest Diagnostics position peaked at $2.53M in Q4 2014.
  • 896 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.

Based on Morningstar Investment Services's 13F filing for Q4 2024, filed 12 Feb 2025.